MYRTOMED

This gallery hangs labelled facts. It does not fill a bottle, write a script, or replace the clinician who has your list. Gallery disclaimer

Five monochrome gallery cards on white paper, carbon type, Copenhagen light

Gallery review · Copenhagen

Five gallery reviews. One nitrate hold.

Tadalafil 5 mg once a day, sildenafil across the 25-100 mg labelled range, vardenafil 2.5 mg after a QT walk, ciprofloxacin 500 mg as a watched course, gabapentin 300 mg with a planned taper. Myrto hangs those locks from the prescribing information. Nothing is sold.

How a review is hung

Hang, measure, walk, close

The order is the same on every page. The labelled milligram is hung first. The nitrate hold, the QT line, the boxed warning, or the taper plan is measured next. Elin Dahl walks the consult, then the page is closed with a date.

01

Hang

The current FDA label first, then a named trial if a number in the text needs one. Marketing copy is not a source.

02

Measure

One labelled lock per page: 5 mg daily, the 25-100 mg range, 2.5 mg after QT, 500 mg as a course, or 300 mg with a taper. The rest of the ladder can be named; the SERP lock stays still.

03

Walk

Reader letters under the profile, answered in Elin's voice, pointed at the same label. Not a clinic visit.

04

Close

A dated review, a freshness stamp, and a link to the gallery disclaimer. If the label moves, the page moves.


The clinician

One Copenhagen internist signs every gallery review

Dr. Elin Dahl reviews each page and answers the consult. Nitrates and PDE5 tablets never mix. A fluoroquinolone boxed warning is not a footnote. Gabapentin is tapered, not dropped.


The review

Three PDE5 clocks on one white wall

The comparison hangs tadalafil 5 mg daily, sildenafil 25-100 mg and vardenafil 2.5 mg side by side on onset, food, QT and the shared nitrate hold. Read it before you pick a profile by brand colour.



Laboratories

The labs and regulators the reviews draw on

Sandwich, Bothell, Wuppertal, Leverkusen, Ann Arbor, Silver Spring, Amsterdam. The history is here so the locks on the profile pages have somewhere to point.

Pfizer Sandwich (former discovery site)

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

Sildenafil began life here as compound UK-92,480, tested first as a treatment for angina. The heart data underwhelmed; a side effect the trial volunteers kept mentioning did not, and the programme was redirected. Viagra, and with it the whole PDE5 class, traces back to this Kent campus.

ICOS Corporation with Eli Lilly

22021 20th Avenue SE, Bothell, WA 98021, USA

Tadalafil was identified at this Washington biotech and carried through late-stage trials in partnership with Eli Lilly. Its defining trait was pharmacokinetic rather than chemical — it cleared the body far more slowly than its rivals, which is the single fact that turned it into the long-window tablet the category now benchmarks against.

Bayer AG, Wuppertal

Aprather Weg 18a, 42113 Wuppertal, Germany

The Wuppertal laboratories produced vardenafil, later marketed as Levitra and the orodispersible Staxyn. Milligram for milligram it binds PDE5 more tightly than either sibling, which is why its labelled doses read so much smaller than sildenafil's.

Bayer AG, Leverkusen

Kaiser-Wilhelm-Allee 1, 51373 Leverkusen, Germany

Ciprofloxacin came out of Bayer's fluoroquinolone programme in the early 1980s — a fluorine atom and a piperazine ring bolted onto the older nalidixic-acid scaffold, producing a broad-spectrum antibiotic that reaches tissues oral drugs usually cannot. The same chemistry explains both its reach and the tendon and nerve cautions now printed in bold on its label.

Parke-Davis / Warner-Lambert (historic)

2800 Plymouth Road, Ann Arbor, MI 48105, USA

Gabapentin was designed at Parke-Davis as a GABA analogue meant to calm over-firing neurons; it never touched GABA receptors as intended, but it damped calcium channels instead and found a durable role in nerve pain and epilepsy. Warner-Lambert, and later Pfizer, took Neurontin from this Michigan research base to market.

U.S. Food and Drug Administration

10903 New Hampshire Avenue, Silver Spring, MD 20993, USA

The American regulator whose approved prescribing information fixes the doses, boxed warnings and interaction rules we quote. Where a page here and the current FDA label diverge, the label is the authority — the nitrate contraindication for the PDE5 drugs and the fluoroquinolone boxed warning above all.

European Medicines Agency

Domenico Scarlattilaan 6, 1083 HS Amsterdam, Netherlands

The EU regulator whose scientific assessments and product information sit alongside the FDA label in our reading. Its reviews are particularly useful on the fluoroquinolone safety restrictions and on the reasoning behind each approved European indication.

Last Updated